Ask questions and gain insights about this stock now with Rize AI
HOLX logo

Hologic, Inc.

HOLX

Stock Analysis

$69.85

+0.00 (+0.00%)• Live

Hologic, Inc. Analysis Dashboard - Stock Analysis and Financial Metrics

Historical Prices

for Hologic, Inc.

Key Financial Metrics

for Hologic, Inc.

2024 FY
P/E Ratio
26.19
Revenue Growth
0.00%
EPS Growth
+81.08%
Market Cap
$14.39B
Dividend Yield
0.00%
Debt/Equity
0.55
ROIC
+7.69%
FCF Yield
+7.23%
View additional metrics

Valuation

P/B Ratio3.16
EV/Sales3.85

Financial Health

Current Ratio3.24
Return on Assets+13.11%

Analyst Recommendations

for Hologic, Inc.

42 analysts
Consensus: Buy

About

for Hologic, Inc.

Company Details

for Hologic, Inc.

Sector

Healthcare

Industry

Medical - Instruments & Supplies

CEO

Stephen P. MacMillan

Employees

7,063

Market Cap

15.54B

Exchange

NASDAQ Global Select

IPO Date

March 1, 1990

CIK

0000859737

ISIN

US4364401012

CUSIP

436440101

Country

US

Balance Sheet

for Hologic, Inc.

Cash Flow Statement

for Hologic, Inc.

Income Statement

for Hologic, Inc.

Rize ist ein KI-gestütztes Investment-Research-Terminal, das eine umfassende Aktienanalyse und Einblicke über ein intuitives Dashboard bietet.

News

No news available at the moment.